Physician profile
Aera Devries
NPI 1124870027
$976.40
in general payments reported to CMS, 2019-2025
11 companies · $976 in 2025
The $976 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.40 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $285.52 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $226.50 | 2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $213.89 | 2025 | Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $53.75 | 2025 | Trelegy Ellipta |
| Pfizer INC. | $43.30 | 2025 | |
| Amgen INC. | $38.91 | 2025 | Otezla, Repatha, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $36.91 | 2025 | |
| Merck Sharp & Dohme LLC | $25.30 | 2025 | Vaxneuvance, Enflonsia, Vaxelis |
| Abbvie INC. | $22.16 | 2025 | |
| Inspire Medical Systems, INC. | $16.59 | 2025 | Inspire |
| Exact Sciences Corporation | $13.57 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aera Devries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.